Elle peut provoquer des arythmies, une hypertension et augmenter le risque d'accident vasculaire.
ArythmiesHypertensionAccident vasculaire
#3
Qu'est-ce qu'une crise thyroïdienne ?
C'est une urgence médicale avec une aggravation soudaine des symptômes d'hyperthyroïdie.
Crise thyroïdienneUrgence médicaleHyperthyroïdie
#4
Quels sont les risques d'une thérapie inappropriée ?
Une thérapie inappropriée peut entraîner des complications graves comme l'agranulocytose.
Thérapie inappropriéeAgranulocytoseComplications
#5
L'hyperthyroïdie peut-elle causer des problèmes osseux ?
Oui, elle peut entraîner une diminution de la densité osseuse et un risque accru d'ostéoporose.
OstéoporoseHyperthyroïdieDensité osseuse
Facteurs de risque
5
#1
Quels sont les facteurs de risque de l'hyperthyroïdie ?
Les facteurs incluent l'âge, le sexe féminin, les antécédents familiaux et certaines maladies auto-immunes.
Facteurs de risqueHyperthyroïdieMaladies auto-immunes
#2
Le tabagisme influence-t-il l'hyperthyroïdie ?
Oui, le tabagisme est un facteur de risque connu, surtout pour la maladie de Graves.
TabagismeMaladie de GravesFacteurs de risque
#3
Les maladies auto-immunes augmentent-elles le risque ?
Oui, des maladies comme la maladie de Graves et la thyroïdite de Hashimoto augmentent le risque.
Maladies auto-immunesMaladie de GravesThyroïdite de Hashimoto
#4
L'exposition à des radiations est-elle un facteur de risque ?
Oui, l'exposition à des radiations peut augmenter le risque de développer une hyperthyroïdie.
RadiationsHyperthyroïdieFacteurs de risque
#5
Le stress peut-il être un facteur de risque ?
Le stress peut exacerber les symptômes, mais n'est pas un facteur de risque direct pour l'hyperthyroïdie.
StressHyperthyroïdieFacteurs de risque
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Antithyroïdiens : Questions médicales les plus fréquentes",
"headline": "Antithyroïdiens : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Antithyroïdiens : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-07",
"dateModified": "2026-03-27",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Antithyroïdiens"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Antihormones",
"url": "https://questionsmedicales.fr/mesh/D006727",
"about": {
"@type": "MedicalCondition",
"name": "Antihormones",
"code": {
"@type": "MedicalCode",
"code": "D006727",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.696.399.450"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Antithyroïdiens",
"alternateName": "Antithyroid Agents",
"code": {
"@type": "MedicalCode",
"code": "D013956",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Hengameh Abdi",
"url": "https://questionsmedicales.fr/author/Hengameh%20Abdi",
"affiliation": {
"@type": "Organization",
"name": "Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran."
}
},
{
"@type": "Person",
"name": "Atieh Amouzegar",
"url": "https://questionsmedicales.fr/author/Atieh%20Amouzegar",
"affiliation": {
"@type": "Organization",
"name": "Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran."
}
},
{
"@type": "Person",
"name": "Fereidoun Azizi",
"url": "https://questionsmedicales.fr/author/Fereidoun%20Azizi",
"affiliation": {
"@type": "Organization",
"name": "Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran."
}
},
{
"@type": "Person",
"name": "Mijin Kim",
"url": "https://questionsmedicales.fr/author/Mijin%20Kim",
"affiliation": {
"@type": "Organization",
"name": "Department of Internal Medicine, Biomedical Research Institute, Pusan National University Hospital, Busan, Korea."
}
},
{
"@type": "Person",
"name": "Stine Linding Andersen",
"url": "https://questionsmedicales.fr/author/Stine%20Linding%20Andersen",
"affiliation": {
"@type": "Organization",
"name": "Department of Clinical Biochemistry, Aalborg University Hospital, Hobrovej 18-22, 9000 Aalborg, Denmark."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Antithyroid drug-induced leukopenia and G-CSF administration: a long-term cohort study.",
"datePublished": "2023-11-07",
"url": "https://questionsmedicales.fr/article/37935745",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-023-46307-5"
}
},
{
"@type": "ScholarlyArticle",
"name": "Clinical characteristics of neutropenic patients under antithyroid drug: Twelve-year experience in a medical center.",
"datePublished": "2023-07-19",
"url": "https://questionsmedicales.fr/article/37466683",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/JCMA.0000000000000966"
}
},
{
"@type": "ScholarlyArticle",
"name": "Effect of iodine nutritional status on the recurrence of hyperthyroidism and antithyroid drug efficacy in adult patients with Graves' disease: a systemic review.",
"datePublished": "2023-10-11",
"url": "https://questionsmedicales.fr/article/37900151",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fendo.2023.1234918"
}
},
{
"@type": "ScholarlyArticle",
"name": "Antithyroid Antibodies and Reproductive Parameters of Women with Hashimoto's Thyroiditis.",
"datePublished": "2024-09-25",
"url": "https://questionsmedicales.fr/article/39320966",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/07435800.2024.2405147"
}
},
{
"@type": "ScholarlyArticle",
"name": "Antithyroid Drug-Induced Agranulocytosis: A Case Report.",
"datePublished": "2023-11-04",
"url": "https://questionsmedicales.fr/article/38054132",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.7759/cureus.48264"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Actions chimiques et utilisations",
"item": "https://questionsmedicales.fr/mesh/D020164"
},
{
"@type": "ListItem",
"position": 3,
"name": "Actions pharmacologiques",
"item": "https://questionsmedicales.fr/mesh/D020228"
},
{
"@type": "ListItem",
"position": 4,
"name": "Effets physiologiques des médicaments",
"item": "https://questionsmedicales.fr/mesh/D045505"
},
{
"@type": "ListItem",
"position": 5,
"name": "Hormones, substituts d'hormones et antagonistes d'hormones",
"item": "https://questionsmedicales.fr/mesh/D006730"
},
{
"@type": "ListItem",
"position": 6,
"name": "Antihormones",
"item": "https://questionsmedicales.fr/mesh/D006727"
},
{
"@type": "ListItem",
"position": 7,
"name": "Antithyroïdiens",
"item": "https://questionsmedicales.fr/mesh/D013956"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Antithyroïdiens - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Antithyroïdiens",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-05-11",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Antithyroïdiens",
"description": "Comment diagnostiquer l'hyperthyroïdie ?\nQuels symptômes indiquent une hyperthyroïdie ?\nQuels tests sont utilisés pour évaluer la fonction thyroïdienne ?\nComment évaluer la gravité de l'hyperthyroïdie ?\nQuel rôle joue l'échographie dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D013956#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Antithyroïdiens",
"description": "Quels sont les signes d'une thyroïdite ?\nComment l'hyperthyroïdie affecte-t-elle le métabolisme ?\nQuels symptômes psychologiques peuvent apparaître ?\nY a-t-il des symptômes oculaires associés ?\nComment l'hyperthyroïdie influence-t-elle le cœur ?",
"url": "https://questionsmedicales.fr/mesh/D013956#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Antithyroïdiens",
"description": "Peut-on prévenir l'hyperthyroïdie ?\nQuel rôle joue l'alimentation dans la prévention ?\nLes antithyroïdiens peuvent-ils être utilisés préventivement ?\nComment le stress influence-t-il la thyroïde ?\nLes antécédents familiaux influencent-ils le risque ?",
"url": "https://questionsmedicales.fr/mesh/D013956#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Antithyroïdiens",
"description": "Quels sont les principaux antithyroïdiens ?\nComment les antithyroïdiens agissent-ils ?\nQuels sont les effets secondaires des antithyroïdiens ?\nQuelle est la durée du traitement par antithyroïdiens ?\nQuand envisager une thérapie à l'iode radioactif ?",
"url": "https://questionsmedicales.fr/mesh/D013956#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Antithyroïdiens",
"description": "Quelles sont les complications de l'hyperthyroïdie ?\nComment l'hyperthyroïdie affecte-t-elle le cœur ?\nQu'est-ce qu'une crise thyroïdienne ?\nQuels sont les risques d'une thérapie inappropriée ?\nL'hyperthyroïdie peut-elle causer des problèmes osseux ?",
"url": "https://questionsmedicales.fr/mesh/D013956#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Antithyroïdiens",
"description": "Quels sont les facteurs de risque de l'hyperthyroïdie ?\nLe tabagisme influence-t-il l'hyperthyroïdie ?\nLes maladies auto-immunes augmentent-elles le risque ?\nL'exposition à des radiations est-elle un facteur de risque ?\nLe stress peut-il être un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D013956#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer l'hyperthyroïdie ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par des tests sanguins mesurant les niveaux de TSH et d'hormones thyroïdiennes."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une hyperthyroïdie ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent perte de poids, nervosité, palpitations et transpiration excessive."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer la fonction thyroïdienne ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent la mesure de la TSH, T3 et T4, ainsi que des scintigraphies thyroïdiennes."
}
},
{
"@type": "Question",
"name": "Comment évaluer la gravité de l'hyperthyroïdie ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gravité est évaluée par les niveaux d'hormones thyroïdiennes et les symptômes cliniques."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'échographie dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'échographie aide à détecter des nodules thyroïdiens et évaluer leur taille et structure."
}
},
{
"@type": "Question",
"name": "Quels sont les signes d'une thyroïdite ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent douleur au cou, fatigue, et parfois des symptômes d'hyperthyroïdie."
}
},
{
"@type": "Question",
"name": "Comment l'hyperthyroïdie affecte-t-elle le métabolisme ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle augmente le métabolisme, entraînant perte de poids et augmentation de l'appétit."
}
},
{
"@type": "Question",
"name": "Quels symptômes psychologiques peuvent apparaître ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme l'anxiété, l'irritabilité et des troubles du sommeil peuvent survenir."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes oculaires associés ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes comme l'exophtalmie peuvent se manifester, surtout dans la maladie de Graves."
}
},
{
"@type": "Question",
"name": "Comment l'hyperthyroïdie influence-t-elle le cœur ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut provoquer des palpitations, une tachycardie et des arythmies cardiaques."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir l'hyperthyroïdie ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de méthode de prévention spécifique, mais un suivi régulier est conseillé."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'alimentation dans la prévention ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée peut aider à maintenir une fonction thyroïdienne normale."
}
},
{
"@type": "Question",
"name": "Les antithyroïdiens peuvent-ils être utilisés préventivement ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, ils ne sont pas utilisés en prévention, mais pour traiter l'hyperthyroïdie existante."
}
},
{
"@type": "Question",
"name": "Comment le stress influence-t-il la thyroïde ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress peut aggraver les symptômes d'hyperthyroïdie, mais ne la cause pas directement."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux influencent-ils le risque ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de maladies thyroïdiennes augmentent le risque d'hyperthyroïdie."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux antithyroïdiens ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les principaux sont le méthimazole et le propylthiouracile, qui inhibent la synthèse d'hormones."
}
},
{
"@type": "Question",
"name": "Comment les antithyroïdiens agissent-ils ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils bloquent la production d'hormones thyroïdiennes en inhibant l'enzyme thyroperoxydase."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires des antithyroïdiens ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires peuvent inclure éruptions cutanées, hépatotoxicité et agranulocytose."
}
},
{
"@type": "Question",
"name": "Quelle est la durée du traitement par antithyroïdiens ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement peut durer de plusieurs mois à plusieurs années, selon la réponse clinique."
}
},
{
"@type": "Question",
"name": "Quand envisager une thérapie à l'iode radioactif ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "La thérapie à l'iode radioactif est envisagée si les antithyroïdiens ne sont pas efficaces."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications de l'hyperthyroïdie ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent l'insuffisance cardiaque, l'ostéoporose et la crise thyroïdienne."
}
},
{
"@type": "Question",
"name": "Comment l'hyperthyroïdie affecte-t-elle le cœur ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut provoquer des arythmies, une hypertension et augmenter le risque d'accident vasculaire."
}
},
{
"@type": "Question",
"name": "Qu'est-ce qu'une crise thyroïdienne ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "C'est une urgence médicale avec une aggravation soudaine des symptômes d'hyperthyroïdie."
}
},
{
"@type": "Question",
"name": "Quels sont les risques d'une thérapie inappropriée ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une thérapie inappropriée peut entraîner des complications graves comme l'agranulocytose."
}
},
{
"@type": "Question",
"name": "L'hyperthyroïdie peut-elle causer des problèmes osseux ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut entraîner une diminution de la densité osseuse et un risque accru d'ostéoporose."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque de l'hyperthyroïdie ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge, le sexe féminin, les antécédents familiaux et certaines maladies auto-immunes."
}
},
{
"@type": "Question",
"name": "Le tabagisme influence-t-il l'hyperthyroïdie ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme est un facteur de risque connu, surtout pour la maladie de Graves."
}
},
{
"@type": "Question",
"name": "Les maladies auto-immunes augmentent-elles le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme la maladie de Graves et la thyroïdite de Hashimoto augmentent le risque."
}
},
{
"@type": "Question",
"name": "L'exposition à des radiations est-elle un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à des radiations peut augmenter le risque de développer une hyperthyroïdie."
}
},
{
"@type": "Question",
"name": "Le stress peut-il être un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress peut exacerber les symptômes, mais n'est pas un facteur de risque direct pour l'hyperthyroïdie."
}
}
]
}
]
}
Division of Endocrinology & Metabolism, Department of Medicine, Thyroid Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Laboratory for Reproductive Immunology, Hospital and Institute of Obstetrics and Gynecology, Shanghai Medical College, Fudan University, Shanghai, China.
The Academy of Integrative Medicine of Fudan University, Shanghai, China.
Shanghai Key Laboratory of Female Reproductive Endocrine-Related Diseases, Shanghai, China.
Laboratory for Reproductive Immunology, Hospital and Institute of Obstetrics and Gynecology, Shanghai Medical College, Fudan University, Shanghai, China.
The Academy of Integrative Medicine of Fudan University, Shanghai, China.
Shanghai Key Laboratory of Female Reproductive Endocrine-Related Diseases, Shanghai, China.
Laboratory for Reproductive Immunology, Hospital and Institute of Obstetrics and Gynecology, Shanghai Medical College, Fudan University, Shanghai, China.
The Academy of Integrative Medicine of Fudan University, Shanghai, China.
Shanghai Key Laboratory of Female Reproductive Endocrine-Related Diseases, Shanghai, China.
Laboratory for Reproductive Immunology, Hospital and Institute of Obstetrics and Gynecology, Shanghai Medical College, Fudan University, Shanghai, China.
The Academy of Integrative Medicine of Fudan University, Shanghai, China.
Shanghai Key Laboratory of Female Reproductive Endocrine-Related Diseases, Shanghai, China.
Laboratory for Reproductive Immunology, Hospital and Institute of Obstetrics and Gynecology, Shanghai Medical College, Fudan University, Shanghai, China.
The Academy of Integrative Medicine of Fudan University, Shanghai, China.
Shanghai Key Laboratory of Female Reproductive Endocrine-Related Diseases, Shanghai, China.
Laboratory for Reproductive Immunology, Hospital and Institute of Obstetrics and Gynecology, Shanghai Medical College, Fudan University, Shanghai, China.
The Academy of Integrative Medicine of Fudan University, Shanghai, China.
Shanghai Key Laboratory of Female Reproductive Endocrine-Related Diseases, Shanghai, China.
Laboratory for Reproductive Immunology, Hospital and Institute of Obstetrics and Gynecology, Shanghai Medical College, Fudan University, Shanghai, China.
The Academy of Integrative Medicine of Fudan University, Shanghai, China.
Shanghai Key Laboratory of Female Reproductive Endocrine-Related Diseases, Shanghai, China.
Although antithyroid drug (ATD)-induced agranulocytosis is a significant concern, its risks associated with long-term use and re-administration are not fully elucidated. Therefore, we performed this s...
Thionamide-induced agranulocytosis (TiA) is a rare adverse event with a reported incidence of approximately 0.1% to 1.75%. Prompt recognition of TiA is critical to reduce the mortality rate. However, ...
This was a retrospective cohort study of patients treated with antithyroid drugs (ATDs) in Taipei Veterans General Hospital, Taipei, Taiwan, from 2006 to 2018. Patients who developed a neutropenic eve...
Among 6644 patients treated with ATDs, 66 (mean age: 53 ± 15 years; 16.2% men) developed a neutropenic event and 20 were diagnosed with TiA (incidence: 0.3%). In the univariate analysis, compared with...
Patients with TiA were more likely to have higher levels of free T4 and ANC at the time of the neutropenic event vs those with non-TiA neutropenia....
To probe the appropriate iodine nutritional status for patients with Graves'disease (GD) hyperthyroidism and on antithyroid drugs (ATD) or after drugwithdrawal....
Studies were retrieved from three databases (Embase, Medline, and Cochrane Library) and were screened and evaluated using predefined criteria. The risk of bias of each trial was assessed using a tool ...
Two randomized controlled trials (RCTs) and 3 observational studies were selected from the 376 retrieved papers, which had different degrees of risk of bias in study design. The heterogeneity among th...
Although the available evidence is suboptimal, this systematic review tentatively suggests that in adult patients with GD hyperthyroidism receiving ATDs and according to WHO criteria for iodine nutrit...
identifier CRD42022359451....
To evaluate the presence and concentration of antithyroid peroxidase (TPOAb) and antithyroglobulin (TGAb) antibodies at the onset of Hashimoto's Thyroiditis (HT) and their association with disease cha...
This is a cross-sectional study with 65 women with HT followed in an outpatient clinic. The data was collected by interviews and review of medical records. The variables were characteristics of the di...
The mean age at diagnosis was 38 (SD ± 11.1) years and the duration of the disease was 7.5 (SD ± 5.3) years; 46% of the women reported infertility periods. 59/65 (90.7%) women had TPOAb and 42 (64.6%)...
The presence of autoantibodies did not influence reproductive parameters; TPOAb concentration was correlated with premature births and thyroid volume....
Agranulocytosis is a rare but life-threatening complication of methimazole and propylthiouracil, antithyroid drugs (ATDs) prescribed for the treatment of hyperthyroidism. We report the case of a 41-ye...
Primary biliary cholangitis (PBC) is an autoimmune disease of liver that may be associated with other conditions, including autoimmune thyroid diseases. We aimed to investigate the frequency of anti-t...
Sera of 80 patients with PBC were collected over a 9-year period. A total of 189 healthy blood donors (HBD) were included in the control group. Measurements of TPO-Ab and TG-Ab were performed using in...
Antithyroid antibodies (ATA) were significantly more frequent in PBC patients than in the control group (13.7% vs 1.6%; P < 10-3). Out of 11 patients with ATA, 10 (90.9%) were female. Nine patients an...
This study shows that PBC is associated with a high frequency of ATA but not TG-Ab or TSHR-Ab....
This is a report on antithyroid arthritis syndrome (AAS) which is a rare adverse effect of antithyroid agents. AAS presents with severe symptoms including myalgia, arthralgia, arthritis, fever, and sk...
Clinicians should be aware of the possibility of developing antithyroid arthritis syndrome (AAS) in patients treated with antithyroid medications, which can lead to severe migratory polyarthritis. Pro...
Hypokalemia is a common laboratory finding in hospitalized patients, typically resulting from insufficient potassium intake, renal or gastrointestinal losses, or intracellular shifts. While the underl...
This review summarizes the diagnosis and management of thyrotoxicosis in pregnancy. The diagnostic clinical and biochemical considerations used to distinguish the various etiologies of hyperthyroidism...
Subacute thyroiditis is also known as subacute granulomatous thyroiditis, giant cell thyroiditis, painful thyroiditis, and De Quervain's thyroiditis. Immature granulocytes (IG) and neutrophil-to-lymph...
The study included 41 patients with subacute thyroiditis treated and monitored in our outpatient clinic between April 2020 and April 2022. From a retrospective review of medical records, we recorded r...
Overall, 31 (75.6%) patients were women and 10 (21.4%) were men. The median age was 41 years (range 22-68 years). The laboratory tests showed the following median (range) results: IG, 0.03 (0.01-0.08)...
Early diagnosis and treatment of subacute thyroiditis is fundamental. In the present study, the new inflammatory markers IG and NLR, measured routinely on CBC tests, decreased significantly after suba...